Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes

Figure 5

Proportion of nonpathogenic variants, pathogenic variants, and VUS in testing only BRCA1/2 genes or testing multiple genes simultaneously. The rate of VUS is expected to increase with the introduction of multigene panels.